II. Epidemiology
- Most common cause of Microcytic Anemia (50% of cases)
- Most common nutritional disorder worldwide
-
Incidence (U.S.)
- Children 1-5 years: 1-2%
- Rare before age 6 months in term infants
- Rare until birth weight doubles in Preterm Infants
- Men: 2-3%
- Women (non-pregnant): 12% when menstruating
- Children 1-5 years: 1-2%
- References
III. Causes
- Children
- Premenopausal women
- Menorrhagia: 2 mg/day iron lost
- Dietary Iron absorption: 1.5 - 1.8 mg/day iron gained
- Each Pregnancy: 500 to 1000 mg iron lost
- Males and Postmenopausal women
- Colon Cancer until proven otherwise
- Gastrointestinal blood Loss
- Gastritis from NSAID use
- Peptic Ulcer Disease
- Partial gastrectomy
- Bariatric Surgery (Gastric Bypass)
- Diverticulosis
- Gastrointestinal Angiodysplasia
- Ulcerative Colitis
- Celiac Sprue
- Increased iron requirements
- Pregnancy (see above)
- Childhood
- Uncommon Causes
- Gastrointestinal Parasites (e.g. Hookworms)
- Gastrointestinal blood loss in long distance Running
- Hereditary Hemorrhagic Telangiectasia
- Pulmonary Hemosiderosis
IV. Symptoms and Signs
- See Pica
- See Anemia Signs
- Change in stool color (Melena or bright red blood)
- History of excessive menstrual flow (Menorrhagia)
- Gastrointestinal condition history or Family History
- Medication usage predisposing to GI Bleeding
V. Associated Conditions
- Generalized Pruritus
- Restless Leg Syndrome
- Glossitis
- Angular Cheilitis
- Fatigue
- Developmental Delay in children
VI. Labs
-
Complete Blood Count (CBC)
- See Hemoglobin Cutoffs for Anemia
- See Hematocrit Cutoffs for Anemia
- Mean Corpuscular Volume (MCV)
- General
- See MCV Cutoffs for Microcytic Anemia
- MCV cutoff varies by age and per reference
- MCV usually <75 in Iron Deficiency Anemia
- MCV >95 fl virtually excludes Iron Deficiency (Test Sensitivity >97%)
- Normocytic Anemia (MCV 80 to 100 fl)
- Normocytic early in course of Anemia
- Normocytic erythrocytes are found in 40% of Iron Deficiency patients
- Microcytic Anemia (MCV <80 fl)
- Microcytosis follows Hemoglobin drop of 2 g/dl
- General
- Red Cell Distribution Width (RDW)
- Precedes change in Mean Corpuscular Volume
- Mean Corpuscular Volume to Red Blood Cell Count ratio
- See Mentzer Index
- Ratio <13: Thalassemia
- Ratio >13: Iron Deficiency Anemia, Hemoglobinopathy
-
Iron Studies (in order of sensitivity)
- Serum Ferritin <30-45 ng/ml (usually <15-20 ng/ml)
- Falls before other indices
- Most sensitive for Iron Deficiency Anemia
- Serum Ferritin <30ng/ml is 92% sensitive and 98% specific for Iron Deficiency
- Falsely elevated as acute phase reactant
- Serum Ferritin <50 ng/ml cutoff is used in Iron Deficiency with inflammatory states
- Serum Ferritin >100 ng/ml excludes Iron Deficiency despite inflammatory state
- Total Iron Binding Capacity (TIBC) rises
- Serum Iron
- Falls after Serum Ferritin
- Falls after Total Iron Binding Capacity (TIBC)
- Transferrin Saturation decreased (<5-9%)
- Serum Iron to Total Iron Binding Capacity
- Falls after Serum Ferritin
- Serum Transferrin receptor assay (new)
- Increased in Iron Deficiency Anemia
- Normal in Anemia of Chronic Disease
- Serum Ferritin <30-45 ng/ml (usually <15-20 ng/ml)
- Other diagnostic tests (indicated in unclear diagnosis)
- Soluble Transferrin Receptor
- Indirect measure of Erythropoiesis
- Increased in Iron Deficiency
- Not affected by inflammatory states
- Erythrocyte Protoporphyrin level
- Heme precursor
- Increased in Iron Deficiency
- Similar timing as with Transferrin Saturation
- Bone Marrow Biopsy
- Indicated when diagnosis is unclear despite above testing
- Soluble Transferrin Receptor
-
Reticulocyte Count or Reticulocyte Index
- Useful in categorization of Anemia type
- Does not assess degree of Iron Deficiency Anemia
- Images
VII. Differential Diagnosis
VIII. Precautions: Identify a source of blood loss
- High correlation to Colon Cancer in older patients
- Exercise caution in adult men and postmenopausal women with Iron Deficiency Anemia
- Ioannou (2002) Am J Med 113:276-80 [PubMed]
IX. Management
- Children
- See Pediatric Anemia
-
Iron Supplementation
- Bone Marrow response limited to 20 mg/day iron
- Typical adult dosing
- See Ferrous Sulfate for administration precautions
- Iron absorption reduced up to 40% when taken with meals
- Further absorption is reduced with gastric acid hyposecretion (e.g. Proton Pump Inhibitor use)
- Elemental iron: 120 mg orally daily
- Ferrous Sulfate: 325 mg orally daily
- Continue Ferrous Sulfate 325 mg orally daily for at least 3 months
- Additional 1-3 months may be required to replenish iron stores
- See Ferrous Sulfate for administration precautions
- Anticipated response
- Hemoglobin increases 1 gram/dl every 2-3 weeks
- Iron stores normalize after Hemoglobin is corrected
- May require additional 4 months to normalize
- Example timeline
- Week 2: Reticulocytosis (<10%)
- Week 3: Increased Hemoglobin Halfway to normal
- Week 8: Normal Hemoglobin
- Evaluate failure to respond to Iron Supplementation
- Noncompliance
- Poor iron absorption due to concurrent medications
- Concurrent Antacid use
- Continued excessive blood loss
- Consider Parenteral Iron if true malabsorption
X. Resources: Patient Education
- Information from your Family Doctor: Iron Deficiency